Suppr超能文献

一项实施研究综合框架(CFIR)指导下的关于关键信息提供者对在初级保健中建立药剂师主导的抗凝服务的观点的探索性定性研究。

A consolidated framework for implementation research (CFIR) guided exploration of key informant perspectives on establishing a pharmacist-led anticoagulation service in primary care: a qualitative study.

作者信息

Alshihab Safaa, Ibrahim Mohamed Izham Mohamed, Al-Zaidan Manal, Hadi Muhammad Abdul

机构信息

Department of Clinical Pharmacy and Practice, College of Pharmacy, QU Health Sector, Qatar University, Doha, Qatar.

Pharmacy and Therapeutics Supply Department, Primary Health Care Corporation, Doha, Qatar.

出版信息

Int J Clin Pharm. 2025 Apr;47(2):335-344. doi: 10.1007/s11096-024-01830-x. Epub 2024 Nov 19.

Abstract

BACKGROUND

Globally, pharmacist-led anticoagulation services have improved patient outcomes in secondary and tertiary care settings. However, there is a paucity of literature about establishing such services within primary care settings.

AIM

This study explored key informants' perceptions regarding the systemic and procedural factors influencing development and implementation of a pharmacist-led anticoagulation service in a primary care setting.

METHOD

A descriptive qualitative study was conducted at Qatar's largest primary healthcare institution, the Primary Health Care Corporation (PHCC). Selected key informants, including healthcare center managers, pharmacy leads, physician leads and primary care physicians with cardiology privileges, were purposively recruited. Semi-structured interviews were guided by the Consolidated Framework for Implementation Research (CFIR) and analyzed using framework analysis.

RESULTS

Elven key informants were interviewed. The participants expressed confidence in the feasibility and effectiveness of implementing anticoagulation service in primary care to address patients' needs. Key factors (mapped to CFIR domains) included ensuring pharmacist competency (Characteristics of Individuals), establishing effective internal and external communication (Inner and Outer Setting), and addressing staffing shortages (Inner Setting). Participants also emphasized on developing standardized operational protocols and training programs (Process), as well as integrating services with secondary care (Outer Setting). Despite challenges such as staffing, participants believed the service would effectively address patient needs if adequately supported.

CONCLUSION

The implementation of pharmacist-led anticoagulation services in primary care settings was identified as both feasible and essential for improving patient outcomes. The insights from this study can inform future initiatives aimed at enhancing anticoagulation management in primary care settings.

摘要

背景

在全球范围内,由药剂师主导的抗凝服务已在二级和三级医疗机构中改善了患者的治疗效果。然而,关于在基层医疗环境中建立此类服务的文献却很少。

目的

本研究探讨了关键信息提供者对于影响在基层医疗环境中开展由药剂师主导的抗凝服务的系统和程序因素的看法。

方法

在卡塔尔最大的基层医疗保健机构——基层医疗保健公司(PHCC)开展了一项描述性定性研究。有目的地招募了选定的关键信息提供者,包括医疗中心经理、药房负责人、医师负责人以及具有心脏病学诊疗权限的基层医疗医生。半结构化访谈以实施研究综合框架(CFIR)为指导,并采用框架分析法进行分析。

结果

共访谈了11名关键信息提供者。参与者对在基层医疗中实施抗凝服务以满足患者需求的可行性和有效性表示有信心。关键因素(映射到CFIR领域)包括确保药剂师能力(个体特征)、建立有效的内部和外部沟通(内部和外部环境)以及解决人员短缺问题(内部环境)。参与者还强调制定标准化操作方案和培训计划(过程),以及将服务与二级医疗相结合(外部环境)。尽管存在人员配备等挑战,但参与者认为如果获得充分支持,该服务将有效满足患者需求。

结论

在基层医疗环境中实施由药剂师主导的抗凝服务被认为对于改善患者治疗效果既可行又至关重要。本研究的见解可为未来旨在加强基层医疗环境中抗凝管理的举措提供参考。

相似文献

2
3
Enhancing medication management of older adults in Qatar: healthcare professionals' perspectives on challenges, barriers and enabling solutions.
Ther Adv Drug Saf. 2024 Oct 7;15:20420986241272846. doi: 10.1177/20420986241272846. eCollection 2024.
4
Exploring stakeholder perceptions of implementing a pharmacist-led anticoagulation clinic in primary care settings: a cross-sectional study.
J Pharm Policy Pract. 2024 Sep 6;17(1):2395529. doi: 10.1080/20523211.2024.2395529. eCollection 2024.
5
Identifying Implementation Factors for the Development, Operation, and Sustainment of Ambulatory Care Pharmacy Programs: a Qualitative Study.
J Gen Intern Med. 2023 Nov;38(15):3381-3388. doi: 10.1007/s11606-023-08375-1. Epub 2023 Aug 24.
6
9
Cardiovascular disease risk screening by pharmacists: a behavior change wheel guided qualitative analysis.
Res Social Adm Pharm. 2020 Feb;16(2):149-159. doi: 10.1016/j.sapharm.2019.04.009. Epub 2019 Apr 16.
10
Pharmacists' facilitators and barriers to implementing and billing for patient care services: Interviews from the Ohio Medicaid Project.
J Am Pharm Assoc (2003). 2023 Jul-Aug;63(4):1077-1086. doi: 10.1016/j.japh.2023.04.009. Epub 2023 Apr 17.

引用本文的文献

1
The role of pharmacists in the management of patients with atrial fibrillation: A systematic review and meta-analysis.
Can Pharm J (Ott). 2025 Aug 31:17151635251365148. doi: 10.1177/17151635251365148.

本文引用的文献

1
Exploring stakeholder perceptions of implementing a pharmacist-led anticoagulation clinic in primary care settings: a cross-sectional study.
J Pharm Policy Pract. 2024 Sep 6;17(1):2395529. doi: 10.1080/20523211.2024.2395529. eCollection 2024.
2
Community-Based Pharmacist Anticoagulation Clinic Outcomes Compared with Physician Management.
Innov Pharm. 2024 Mar 18;15(1). doi: 10.24926/iip.v15i1.5929. eCollection 2024.
3
The quality of pharmacist-led community warfarin management across 2 provinces in Canada: A cross-sectional observational study.
Can Pharm J (Ott). 2024 Feb 5;157(2):77-83. doi: 10.1177/17151635241228228. eCollection 2024 Mar-Apr.
4
Evaluation of warfarin management in primary health care centers in Qatar: A retrospective cross-sectional analysis of the national dataset.
Curr Probl Cardiol. 2024 Apr;49(4):102427. doi: 10.1016/j.cpcardiol.2024.102427. Epub 2024 Jan 30.
5
The updated Consolidated Framework for Implementation Research based on user feedback.
Implement Sci. 2022 Oct 29;17(1):75. doi: 10.1186/s13012-022-01245-0.
7
A Qualitative Systematic Review of Facilitators of and Barriers to Community Pharmacists-Led Anticoagulation Management Service.
Ann Pharmacother. 2022 Jun;56(6):704-715. doi: 10.1177/10600280211045075. Epub 2021 Sep 11.
8
Clinical services in community pharmacies: a scoping review of policy and social implications.
Int J Pharm Pract. 2021 Mar 17;29(2):116-125. doi: 10.1093/ijpp/riaa007.
9
A review of indications and comorbidities in which warfarin may be the preferred oral anticoagulant.
J Clin Pharm Ther. 2021 Jun;46(3):560-570. doi: 10.1111/jcpt.13343. Epub 2021 Jan 4.
10
A novel model of care in anticoagulation management.
Healthc Manage Forum. 2020 Nov;33(6):247-252. doi: 10.1177/0840470420969444. Epub 2020 Oct 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验